Biologics and Drug Delivery - Disposable Products23%
Capital Equipment and Software Revenue10%
Capital Equipment and Software - Systems and Software Products5%
Capital Equipment and Software - Services4%
By geography
Not disclosed.
The read
ClearPoint Neuro, Inc. booked $37.0M in FY2025 revenue, growing 18% year over year — faster than most Healthcare companies we track, at a -69.1% net margin.
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.